Albireo Pharma Inc. buy Mori8
Start price
15.12.16
/
50%
€20.99
Target price
08.03.17
€26.05
Performance (%)
4.86%
End price
08.03.17
€22.01
Summary
This prediction ended on 08.03.17 with a price of €22.01. The BUY prediction by Mori8 finished with a performance of 4.86%. Mori8 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Albireo Pharma Inc. | - | - | - | - |
iShares Core DAX® | 0.597% | 3.083% | 16.090% | 16.439% |
iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% | 56.431% |
iShares Nikkei 225® | 1.775% | -1.206% | 6.823% | 4.774% |
iShares S&P 500 | 0.990% | 3.500% | 24.956% | 47.182% |
Comments by Mori8 for this prediction
In the thread Albireo Pharma Inc. diskutieren
Mori8 stimmt der Buy-Einschätzung von Quitte zu
Mori8 stimmt am 15.12.2016 der Buy-Einschätzung von Quitte mit dem Kursziel 21€ zu.Überschrift: schuldenfrei und Merger in Sicht
(Vom Mitglied beendet)
Stopped prediction by Mori8 for Albireo Pharma Inc.
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€21.25
14.03.17
14.03.17
€28.28
13.07.17
13.07.17
5.88%
13.07.17
13.07.17
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€11.04
20.09.16
20.09.16
€17.64
14.12.16
14.12.16
111.06%
14.12.16
14.12.16